In Japan, frameworks for social implementation are advancing, including R&D of cell-free immunomodulation
using
#exosomes, guideline development by the
#PMDA, and support for manufacturing, clinical application,
and startup creation.
Check👉
sj.jst.go.jp/news/202605/n05…
ALT Designer exosomes that simultaneously present antigen-MHC complexes, co-stimulatory molecules (CD80), and cytokines (IL-2) act on killer T cells and activate them. The activated killer T cells secrete cytotoxic factors to eliminate tumor cells.
Provided by Kanazawa University